Clinical Characteristics of Coronavirus Disease 2019 in Dr. Agoesdjam Regional Public Hospital, Ketapang, West Kalimantan, Indonesia


  • Herick Alvenus Willim General Practitioner, Dr. Agoesdjam Regional Public Hospital, Ketapang Regency, West Kalimantan
  • Cristianto Cristianto General Practitioner, Dr. Agoesdjam Regional Public Hospital, Ketapang Regency, West Kalimantan
  • Yohana Roy Ito Br Sihombing General Practitioner, Dr. Agoesdjam Regional Public Hospital, Ketapang Regency, West Kalimantan
  • Eva Lydia Munthe Department of Pulmonology and Respiratory Medicine, Dr. Agoesdjam Regional Public Hospital, Ketapang Regency, West Kalimantan
  • Widi Mujono Department of Radiology, Dr. Agoesdjam Regional Public Hospital, Ketapang Regency, West Kalimantan
  • Enny Enny Department of Clinical Pathology, Dr. goesdjam Regional Public Hospital, Ketapang Regency, West Kalimantan


Background: Coronavirus disease 2019 (COVID-19) is a new pandemic caused by SARS-CoV-2 infection. COVID-19 has spread to almost all countries with increasing cases, including Indonesia. Data on the clinical characteristics of COVID-19 in Indonesia is still limited. This study aimed to determine the clinical characteristics of COVID-19.

Subjects and Method: This study was a descriptive study with a retrospective design conducted in Dr. Agoesdjam Regional Public Hospital. The data were obtained from the medical records of all patients with confirmed COVID-19 from April 1 to July 31, 2020. There were 50 patients as the sample of the study. The data collected were demographics, expo


Akcay S, Ozlu T, Yilmaz A (2020). Radio-logical approaches to COVID-19 pneumonia. Turk J Med Sci, 50(3): 604

Alqahtani SA, Schattenberg JM (2020). Liver injury in COVID-19: the current evidence. United European Gastro-enterol J, 8(5): 509

Amaratunga EA, Corwin DS, Moran L, Sny-der R (2020). Bradycardia in patients with COVID-19: a calm before the storm? Cureus, 12(6): e8599. doi: 10.-7759/cureus.8599.

Angeli F, Spanevello A, Ponti RD, Visca D, Marazzato J, Palmiotto G, Feci D, et al. (2020). Electrocardiographic features of patients with COVID-19 pneumonia. Eur J Intern Med, 78: 101

Arshad S, Kilgore P, Chaudhry ZS, Jacobsen G, Wang DD, Huitsing K, Brar I, et al. (2020) Treatment with hydroxy-chloroquine, azithromycin, and com-bination in patients hospitalized with COVID-19. Int J Infect Dis, 97: 396

Bwire GM (2020). Coronavirus: why men are more vulnerable to Covid-19 than women? SN Compr Clin Med. doi: 10.1007/s42399-020-00341-w.

Cai G, Bosse Y, Xiao F, Kheradmand F, Amos CI (2020). Tobacco smoking increases the lung gene expression of ACE2, the receptor of SARS-CoV-2. Am J Respir Crit Care Med, 201(12): 1557

Cai Q, Huang D, Yu H, Zhu Z, Xia Z, Su Y, Li Z, et al. (2020). COVID-19: abnor-mal liver function tests.J Hepatol, 73(3): 566

Cao Z, Li T, Liang L, Wang H, Wei F, Meng S, Cai M, et al. (2020). Clinical characteristics of coronavirus disease 2019 patients in Beijing, China.PLoS One, 15(6): e0234764. doi: 10.1371/journal.pone.0234764.

Chorin E, Wadhwani L, Magnani S, Dai M, Shulman E, Nadeau-Routhier C, Knotts R, et al. (2020). QT interval prolongation and torsade de pointes in patients with COVID-19 treated with hydroxychloroquine/azithromycin. Heart Rhythm, 17(9):1425-1433. doi: 10.1016/j.hrthm.2020.05.014.

Cleverley J, Piper J, Jones MM (2020). The role of chest radiography in confirming covid-19 pneumonia. BMJ, 370: m2426. doi: 10.1136/bmj.m2426.

Colaneri M, Sacchi P, Zuccaro V, Biscarini S, Sachs M, Roda S, Pieri TC, et al. (2020). Clinical characteristics of coronavirus disease (COVID-19) early findings from a teaching hospital in Pavia, North Italy, 21 to 28 February 2020.Euro Surveill, 25(16): 2000460. doi: 10.2807/15607917.ES.2020.25.16.2000460.

Cozzi D, Albanesi M, Cavigli E, Moroni C, Bindi A, Luvara S, Lucarini S, et al. (2020). Chest x-ray in new corona-virus disease 2019 (COVID-19) infec-tion: findings and correlation with clinical outcome. Radiol Med. doi: 10.1007/s11547-020-01232-9.

Dhand R, Li J (2020). Coughs and sneezes: their role in transmission of respira-tory viral infections, including SARS-CoV-2. Am J Respir Crit Care Med, 202(5): 651-659. doi: 10.1164/rccm.202004-1263pp.

Dinas Kesehatan Kalimantan Barat (2020). Dashboard COVID-19 Kalbar. Available at: (Accessed 3 September 2020).

Elezkurtaj S, Greuel S, Ihlow J, Michaelis E, Bischoff P, Kunze CA, Sinn VB, et al. (2020). Causes of death and comorbidities in patients with COVID-19. MedRxiv Preprint. doi: 10.1101/20-

Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Mailhe M, Doudier B, et al. (2020). Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-ran-domized clinical trial. Int J Anti-microb Agents, 56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949.

Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, Liu L, et al. (2020). Clinical charac-teristics of coronavirus disease 2019 in China. N Engl J Med, 382:1708-1720. doi: 10.1056/NEJMoa2002032.

Hafiz M, Icksan AG, Harlivasari AD, Aulia R, Susanti F, Eldinia L (2020). Clinical, radiological features and out-come of COVID-19 patients in a secondary hospital in Jakarta, Indonesia. J Infect Dev Ctries, 14(7):750

Hu H, Ma F, Wei X, Fang Y (2020). Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin. Eur Heart J: eha-a190. doi: 10.1093/eurheartj/ehaa190.

Hua J, Shaw R (2020). Corona virus (COVID-19)

Huang G, Kovalic AJ, Graber CJ (2020). Prognostic value of leukocytosis and lymphopenia for coronavirus disease severity. Emerg Infect Dis, 26(8): 1839

Itodo GE, Enitan SS, Oyekale AO, Agunsoye CJ, Asukwo UF, Enitan CB (2020). COVID-19 among healthcare workers: risk of exposure, impacts and biosafety measures

Jajodia A, Ebner L, Heidinger B, Chatur vedi A, Prosch H (2020). Imaging in corona virus disease 2019 (COVID-19) a scoping review.Eur J Radiol Open, 7: 100237. doi: 10.1016/j.ejro.2020.100237.

Jin Y, Yang H, Ji W, Wu W, Chen S, Zhang W, Duan G (2020). Virology, epidemiology, pathogenesis, and control of COVID-19. Viruses, 12(4):372. doi: 10.3390/v12040372.

Karyono DR, Wicaksana AL (2020). Cur-rent prevalence, characteristics, and comorbidities of patients with COVID-19 in Indonesia. JCOEMPH, 3(2): 77-84. doi: 10.22146/jcoemph.57325.

Kho J, Ioannou A, Abbeele KVD, Mandal AKJ, Missouris CG (2020). Pulmonary embolism in COVID-19: clinical characteristics and cardiac implications. Am J Emerg Med. doi: 10.1016-/j.ajem.2020.07.054.

Liao J, Fan S, Chen J, Wu J, Xu S, Guo Y, Li C, et al. (2020). Epidemiological and clinical characteristics of COVID-19 in adolescents and young adults. The Innovation, 1(1): 100001. doi: 10.1016/j.xinn.2020.04.001.

Lippi G, Mattiuzzi, C (2020). Hemoglobin value may be decreased in patients with severe coronavirus disease 2019. Hematol Transfus Cell Ther, 42(2): 116-117. doi: 10.1016/j.htct.2020.03.-001.

Liu J, Liu Y, Xiang P, Pu L, Xiong H, Li C, Zhang M, et al. (2020). Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage.J Transl Med, 18(1): 206. doi: 10.1186/s12967-020-02374-0.

Liu Y, Bi L, Chen Y, Wang Y, Fleming J, Yu Y, Gu Y, et al. (2020). Active or latent tuberculosis increases susceptibility to COVID-19 and disease severity. Med-Rxiv preprint. doi: 10.1101/2020.03.-10.20033795.

Mccullough SA, Goyal P, Krishnan U, Choi JJ, Safford MM, Okin PM (2020) Electrocardiographic findings in coronavirus disease-19: insights on mortality and underlying myocardial processes. J Card Fail, 26(7): 626-632. doi: 10.1016/j.cardfail.2020.06.005.

Merino JL, Martinez-Cossiani M, Iniesta A, Escobar C, Rey JR, Castrejon Castrejon S (2020). COVID-19 and QT interval prolongation: more than just drug toxicity? Europace, euaa145. doi: 10.1093/europace/euaa145.

Pinto BGG, Oliveira AER, Singh Y, Jimenez L, Goncalves ANA, Ogava RLT, et al. (2020). ACE2 expression is increased in the lungs of patients with comorbidities associated with severe CO-VID-19. J Infect Dis, 222(4): 556-563. doi: 10.1093/infdis/jiaa332.

Rodriguez-Morales AJ, Cardona-Ospina JA, Gutierrez-Ocampo E, Villamiraz-Pena R, Holguin-Rivera Y, Escalera-Antezana JP, Alvarado-Arnez LE, et al. (2020). Clinical, laboratory and ima-ging features of COVID-19: a syste-matic review and meta-analysis.

Travel Med Infect Dis, 34: 101623. doi: 10.1016/j.tmaid.2020.101623.

Rosa SGV, Santos WC (2020). Clinical trials on drug repositioning for CO-VID-19 treatment.Rev Panam Salud Publica, 44:e40. doi: 10.26633/RPSP-.2020.40.

Sarkodie BD, Osei-Poku K, Brakohiapa E (2020). Diagnosing COVID-19 from chest x-ray in resource limited envi-ronment-case Report. Med Case Rep, 6(1): 135. doi: 10.36648/2471-8041.-6.2.135.

Sia CH, Ngiam JN, Chew N, Beh DLL, Poh LK (2020). Educational case series of electrocardiographs during the COVID-19 pandemic and the implications for therapy.Singapore Med J, 61(8): 406

Singhal T (2020). A review of coronavirus disease-2019 (COVID-19). Indian J Pediatr, 87(4): 281-286. doi: 10.1007-/s12098-020-03263-6.

Sultana J, Cutroneo PM, Crisafulli S, Puglisi G, Caramori G, Trifiro G (2020). Azithromycin in COVID-19 patients: pharmacological mechanism, clinical evidence and prescribing guidelines. Drug Saf. doi: 10.1007/s40264-020-00976-7.

Violetis OA, Chasouraki AM, Giannou AM, Baraboutis IG (2020). COVID-19 infection and haematological involvement: a review of epidemiology, pathophysiology and prognosis of full blood count findings.SN Compr Clin Med. doi: 10.1007/s42399-020-003-80-3.

World Health Organization (2020). WHO Coronavirus Disease (COVID-19) Dashboard. Available at: (Accessed 3 September 2020).

Wong HYF, Lam HYS, Fong AHT, Leung ST, Chin TWY, Lo CSY, Lui MMS, et al. (2020). Frequency and distribu-tion of chest radiographic findings in patients positive for COVID-19. Radiology, 296(2): E72

Wu R, Wang L, Kuo HCD, Shannar A, Peter R, Chou PJ, Li S, et al. (2020). An update on current therapeutic drugs treating COVID-19. Curr Pharmacol Rep. doi: 10.1007/s40495-020-002-16-7.

Xu B, Xing Y, Peng J, Zheng Z, Tang W, Sun Y, Xu C, et al. (2020). Chest CT for detecting COVID-19: a systematic review and meta-analysis of diagnostic accuracy. Eur Radiol. doi: 10.21203/rs.3.rs20481/v1.

Yavuz SS, Unal S (2020). Antiviral treatment of COVID-19. Turk J Med Sci, 50(3): 611

Zeng F, Huang Y, Guo Y, Yin M, Chen X, Xiao L, Deng G (2020). Association of inflammatory markers with the severity of COVID-19: A meta-analysis.Int J Infect Dis, 96: 467-474. doi: 10.10-16/j.ijid.2020.05.055.

Zhao H, Lu X, Deng Y, Tang Y, Lu J (2020). COVID-19: asymptomatic carrier transmission is an underestimated problem. Epidemiol Infect, 148: e116. doi: 10.1017/S0950268820001235.

Zheng J (2020). SARS-CoV-2: an emerging coronavirus that causes a global threat. Int J Biol Sci, 16(10):1678-1685. doi: 10.7150/ijbs.45053.

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X,et al. (2020). A novel coronavirus from patients with pneumonia in China, 2019.N Engl J Med, 382(8): 727-733. doi: 10.1056/NEJ-Moa2001017.




How to Cite

Willim, H. A., Cristianto, C., Sihombing, Y. R. I. B., Munthe, E. L., Mujono, W., & Enny, E. (2020). Clinical Characteristics of Coronavirus Disease 2019 in Dr. Agoesdjam Regional Public Hospital, Ketapang, West Kalimantan, Indonesia. Journal of Epidemiology and Public Health, 5(3), 293–308. Retrieved from